Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-14T22:03:57.973Z Has data issue: false hasContentIssue false
  • English
  • Français

Innovative ways of treating comorbid diabetes type II and depression: piloting the ‘MADE-IT’ program

Published online by Cambridge University Press:  24 June 2014

L Underwood,
W Burgess,
A Baker and
B Kelly
L Underwood
Affiliation:
Centre of Rural and Remote Mental Health
W Burgess
Affiliation:
Greater Western Area Health Service
A Baker
Affiliation:
Centre for Mental Health Studies, University of Newcastle, Newcastle, Australia
B Kelly
Affiliation:
Centre of Rural and Remote Mental Health
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Information

Type
Abstracts from ‘Brainwaves’— The Australasian Society for Psychiatric Research Annual Meeting 2006, 6–8 December, Sydney, Australia
Information
Acta Neuropsychiatrica , Volume 18 , Issue 6 , December 2006, pp. 272
Copyright
Copyright © 2006 Blackwell Munksgaard

Background:

Both diabetes and depression are considered ‘chronic’ conditions and affect an increasing number of people each year. The pilot phase of an innovative eight-session treatment program using an integrated CBT and diabetes education model was undertaken, prior to commencing a larger randomized controlled trial.

Methods:

Participants with diabetes type II were recruited from two specialist diabetes clinics in New South Wales. Screening was conducted for depressive symptoms (BDI-II), Problem Areas in Diabetes (PAID) Scale, psychological distress (K10) and quality of life. Those with scores >15 on BDI-II were invited to participate. Participants were evaluated on physical and psychological measures pre/posttreatment, and tracked each 2 weeks on BDI-II, PAID Scale and fasting BGL's. Data were analyzed using matched paired t-tests. Qualitative information on the acceptability of the program was gathered.

Results:

Thirteen subjects (7 men/6 women) aged 36–69 years attended sessions once a week for 8 weeks. Significant postintervention improvement was detected in depressive symptoms (P ≤ 0.001), improved diabetes knowledge (P = 0.008) reported number of PAID (P = 0.029) and psychological distress scores (P = 0.001).

Conclusions:

The ‘MADE-IT’ program marries evidence-based interventions for depression and diabetes and looks at the connections between the disorders. The program uses a small group context and has a standardized leader's manual and participant handbook to assist enhance treatment fidelity. While outcomes are positive, the sample is small and no control comparison was included. Further evaluation of the program will be undertaken with a multisite randomized controlled trial in the near future.